US Drug Recall Register

FDA Drug Recalls

11,815 recalls · Class II, newest first

Class II · Moderate risk Terminated

Papaverine/Phentolamine 30mg/0.5mg/Ml

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0226-2023
Class II · Moderate risk Terminated

Nadh 10mg/Ml

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0225-2023
Class II · Moderate risk Terminated

Mitomycin 0.4mg/Ml

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0224-2023
Class II · Moderate risk Terminated

Mitomycin 0.2mg/Ml

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0223-2023
Class II · Moderate risk Terminated

Methylcobalamin 12.5mg/Ml

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0222-2023
Class II · Moderate risk Terminated

Methotrexate Intravitreal

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0221-2023
Class II · Moderate risk Terminated

Magnesium Chloride Hexahydrate-Pf- 200mg/Ml

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0219-2023
Class II · Moderate risk Terminated

Lidocaine-Pf- 5%

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0218-2023
Class II · Moderate risk Terminated

Levemir-Sts- 100u/Ml

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0217-2023
Class II · Moderate risk Terminated

Ketamine 50mg/Ml

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0216-2023
Class II · Moderate risk Terminated

Hydroxocobalamin-Pf- 1mg/Ml

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0215-2023
Class II · Moderate risk Terminated

Glycerin/Lidocaine Hcl/Epinephrine 31%

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0213-2023
Class II · Moderate risk Terminated

GLYCERIN STERILE 99% 2ML VIAL and 5ML VIAL

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0212-2023
Class II · Moderate risk Terminated

Glycerin 72%

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0211-2023
Class II · Moderate risk Terminated

Glutathione L Reduced 100mg/Ml

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0210-2023
Class II · Moderate risk Terminated

Gentamicin Bladder 0.08mg/Ml

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0209-2023
Class II · Moderate risk Terminated

Flurbiprofen -Corn Oil- 0.04%

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0208-2023
Class II · Moderate risk Terminated

Ethyl Alcohol 95%

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0207-2023
Class II · Moderate risk Terminated

Estradiol Cyp/Test Cyp- Ss Oil- 2mg/50mg/Ml

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0206-2023
Class II · Moderate risk Terminated

Estradiol 0.05% OPH Solution

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0205-2023
Class II · Moderate risk Terminated

Edetate Disodium

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0204-2023
Class II · Moderate risk Terminated

Edetate Calcium Disodium 400MG/ML

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0203-2023